| Literature DB >> 36073070 |
Bilqees Achmat1, Berna Gerber.
Abstract
BACKGROUND: Personal protective equipment (PPE) and infection prevention and control (IPC) measures are crucial to preventing the spread of coronavirus disease 2019 (COVID-19). This study used a scoping review to investigate the challenges that exist when speech-language therapists (SLTs) use IPC measures for providing early communication intervention (ECI).Entities:
Keywords: early communication intervention; early intervention; infection control; infection prevention and control measures; personal protective equipment; scoping review, PRISMA-ScR
Mesh:
Year: 2022 PMID: 36073070 PMCID: PMC9453695 DOI: 10.4102/sajcd.v69i2.911
Source DB: PubMed Journal: S Afr J Commun Disord ISSN: 0379-8046
FIGURE 1PRISMA-ScR flow diagram of results.
FIGURE 2Organic network showing the nature of care and behaviour of young children in response to infection prevention and control measures within early communication intervention as reported in the focus group discussions, generated by ATLAS.ti version 9.
FIGURE 3Organic network showing the challenges to conducting early communication intervention when utilising infection prevention and control measures as expressed during the focus group discussions, generated by ATLAS.ti version 9.
Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews (PRISMA-ScR) checklist.
| Section | Item | PRISMA-ScR checklist item | Reported (Yes/No) |
|---|---|---|---|
|
| |||
| Title | 1 | Identify the report as a scoping review. | Yes |
|
| |||
| Structured summary | 2 | Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, charting methods, results and conclusions that relate to the review questions and objectives. | Yes |
|
| |||
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. Explain why the review questions or objectives lend themselves to a scoping review approach. | Yes |
| Objectives | 4 | Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g. population or participants, concepts and context) or other relevant key elements used to conceptualise the review questions and/or objectives. | Yes |
|
| |||
| Protocol and registration | 5 | Indicate whether a review protocol exists; state if and where it can be accessed (e.g. a web address), and if available, provide registration information, including the registration number. | N/A |
| Eligibility criteria | 6 | Specify characteristics of the sources of evidence used as eligibility criteria (e.g. years considered, language and publication status), and provide a rationale. | Yes |
| Information sources | 7 | Describe all information sources in the search (e.g. databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed. | Yes |
| Search | 8 | Present the full electronic search strategy for at least one database, including any limits used, such that it could be repeated. | Yes |
| Selection of sources of evidence | 9 | State the process for selecting sources of evidence (i.e. screening and eligibility) included in the scoping review. | Yes |
| Data charting process | 10 | Describe the methods of charting data from the included sources of evidence (e.g. calibrated forms or forms that have been tested by the team before their use, whether data charting was done independently or in duplicate) and any processes for obtaining and confirming data from investigators. | Yes |
| Data items | 11 | List and define all variables for which data were sought and any assumptions and simplifications made. | Yes |
| Critical appraisal of individual sources of evidence | 12 | If done, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods used and how this information was used in any data synthesis (if appropriate). | N/A |
| Synthesis of results | 13 | Describe the methods of handling and summarising the data that were charted. | Yes |
|
| |||
| Selection of sources of evidence | 14 | Give numbers of sources of evidence screened, assessed for eligibility and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram. | Yes |
| Characteristics of sources of evidence | 15 | For each source of evidence, present characteristics for which data were charted and provide the citations. | Yes |
| Critical appraisal within sources of evidence | 16 | If done, present data on critical appraisal of included sources of evidence (see item 12). | N/A |
| Results of individual sources of evidence | 17 | For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives. | Yes |
| Synthesis of results | 18 | Summarise and/or present the charting results as they relate to the review questions and objectives. | Yes |
|
| |||
| Summary of evidence | 19 | Summarise the main results (including an overview of concepts, themes and types of evidence available), link to the review questions and objectives and consider the relevance to key groups. | Yes |
| Limitations | 20 | Discuss the limitations of the scoping review process. | Yes |
| Conclusions | 21 | Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications and/or next steps. | Yes |
|
| |||
| Funding | 22 | Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review. | Yes |
Source: Tricco, A.C., Lillie, E., Zarin, W., O’Brien, K.K., Colquhoun, H., Levac, D., … Straus, S.E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850
JBI, Joanna Briggs Institute; PRISMA-ScR, Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews.
, Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms and websites.
, A more inclusive or heterogeneous term used to account for the different types of evidence or data sources (e.g. quantitative and/or qualitative research, expert opinion and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote).
, The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting.
, The process of systematically examining research evidence to assess its validity, results and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of ‘risk of bias’ (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g. quantitative and/or qualitative research, expert opinion and policy document).
Data charting table.
| Scoping review details | Data |
|---|---|
| Authors | |
| Year of publication | |
| Source of the selected study | |
| Country where the research was conducted | |
| Research design | |
| Research setting | |
| PPE and/or IPC measure(s) described | |
| Function of or rational for the PPE and IPC measures | |
| Person or team involved | |
| Age range of children | |
| Duration of data collection | |
| Aims | |
| Results | |
| Limitations | |
| Recommendations |
IPC, infection prevention and control; PPE, Personal protective equipment.
Consultation phase (step 6): Interview guide.
| No. | Description |
|---|---|
| 1. | Within the selected studies, there were two significant spikes in relevant infection control research in |
| Do you agree with this connection, or do you think there is another reason for the increase in research | |
| 2. | Can you describe any challenges to using PPE and maintaining IPC practices which are specific to early communication intervention? Please also mention if you do not experience any challenges. |
| 3. | What would you say the primary function of PPE and IPC measures is if you think about prevention of transmission versus simply protecting oneself? |
| 3.1 | Can you share any experiences of how the perceived primary function (protection vs. prevention) affected the use and disposal of PPE by individuals (e.g. staff, patients or caregivers)? |
| 4. | Only one study investigated a childcare facility (e.g. nursery). All other studies were carried out in medical settings. |
| 5. | The research findings support a collaborative team approach to infection control. However, only one of the 14 selected studies included caregivers. |
| 5.1. | What are your views on the use of a ‘team approach’ to infection control? |
| 5.2. | What is your experience of including caregivers in IPC strategies within ECI? |
| 6. | To what extent do you relate to the barriers to IPC measures described in the research findings? |
| 6.1. | Do you experience or are you aware of any additional barriers to IPC measures within |
| 7. | To what extent do you agree or disagree with the recommendations for IPC measures in early |
| 7.1. | Can you suggest any additional recommendations for infection control used in early |
| 8. | What recommendations do you have for future research regarding PPE and IPC measures in ECI |
| 9. | Was there something else you would have wanted to know in relation to the research findings? |
IPC, infection prevention and control; PPE, Personal protective equipment; ECI, early communication intervention.
Characteristics of included studies.
| Article # | Author and date | Source | Country and income level | Setting | PPE and/or IPC measures | Person/team involved |
|---|---|---|---|---|---|---|
| 1 | Triantafillou et al. ( | EBSCOhost | Greece (high income) | Medical | IPC measures | Medical staff & nurses |
| 2 | Salem and Youssef ( | EBSCOhost | Egypt (low income) | Medical | IPC measures | Medical staff & nurses |
| 3 | Wong, Xu, Bone, and Srigley ( | EBSCOhost | Canada (high income) | Medical | IPC measures | HCWs & hospital teacher |
| 4 | Dramowski et al. ( | University of Stellenbosch Library | South Africa (middle income) | Medical | IPC measures | Medical staff |
| 5 | Reid et al. ( | Professionals | Canada (high income) | Medical | PPE & IPC measures | Medical staff |
| 6 | Yin et al. ( | Professionals | United States of America (high income) | Medical | PPE (gloving) | HCWs |
| 7 | Gupta and Pursley ( | References | United States of America (High income) | Medical | IPC measures | Medical staff |
| 8 | Ibfelt et al. ( | References | Denmark (high income) | Nonmedical (nursery) | IPC measures | Nursery carers |
| 9 | Gras-Valentí et al. ( | References | Spain (high income) | Medical | IPC measures | HCWs |
| 10 | Olivier et al. ( | References | South Africa (middle income) | Medical | IPC measures | HCWs |
| 11 | Lorenzini et al. ( | References | Brazil (middle income) | Medical | IPC measures | Nurses |
| 12 | Buser et al. ( | EBSCOhost | United States of America (high income) | Medical | IPC measures | HCWs & parents |
| 13 | Freitas, Alves, and Gaíva ( | Google Scholar | Brazil (middle income) | Medical | PPE & IPC measures | HCWs |
| 14 | Verma et al. ( | United States of America (high income) | Medical | PPE & IPC measures | Medical staff & nurses |
IPC, infection prevention and control; HCWs, health care workers; PPE, Personal protective equipment.